ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
ZACKSHoldTECHNeutral
R500#378 today
$259.93
-0.63% today · -1.96% 1W
Oct 1 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- ABBV −0.63% on the last session vs SPY +0.18%: −0.8 pts of stock-specific move.
- 1 insider or congressional trade in the past 30 days.
- Market backdrop (Wed): Core PCE Price Index m/m 0.2% vs 0.3% expected (cooler); Final GDP q/q 2.2% vs 1.5% expected (stronger); S&P futures +0.18%, 10-year yield +0bp in the 30 minutes after.
Assembled from Wallsti's own signals. The news-reading agent will explain the move with timestamped sources, and say so when there is no clear catalyst.
ABBV against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #378 | -0.63% | +0.18% | |
| 1 week | #335 | -1.96% | -0.42% | |
| 1 month | #133 | -0.02% | +0.54% | |
| 3 months | #148 | +4.27% | +2.70% | |
| 6 months | #100 | +22.78% | +17.19% | |
| 1 year | #215 | +9.66% | +15.53% | |
| Overall | #173 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Drug Manufacturers - General
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | 0.09 | #416 | #5 |
| fPE/tPE | 0.22 | #19 | #2 |
| PE/G | 0.54 | #38 | #1 |
| EV/Revenue | 8.18 | #94 | #2 |
| Gross Margin | 0.73 | #70 | #6 |
| Profit Margin | 0.10 | #324 | #5 |
| Revenue Growth | 0.10 | #226 | #2 |